AstraZeneca Says Imfinzi Combo Shows Promise in Lung Cancer Trial AstraZeneca Says Imfinzi Combo Shows Promise in Lung Cancer Trial
AstraZeneca said a combination of its cancer drug, Imfinzi, and chemotherapy showed promise in a late-stage trial in patients with an aggressive form of lung cancer, when given before surgery.Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology News Source Type: news
More News: AstraZeneca | Cancer | Cancer & Oncology | Chemotherapy | Hematology | Lung Cancer | Surgery